__________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________

Image icon of a document representing a questionnaire to enable people with MS to come better prepared for their consultations.

A simple questionnaire to enable people with MS to come better prepared for their consultations.

 

 

  • Optimises consultation structure and efficiency
  • Developed with multiple sclerosis (MS) experts and patients with MS 

Why use the YourMS questionnaire?

Tracking MS symptoms over time can be challenging

  • Patient input is essential in identifying changes in MS1
  • Objective assessment and structure in monitoring MS symptoms can lead to improvements in recognising the subtle signs of worsening MS2

Monitoring changes in MS symptoms is critical in identifying the most appropriate management approach.3 HCPs typically rely on:

 

Image icon of 2 speech bubbles representing 'Asking questions'

 

Asking questions

Image icon of a checklist representing 'Taking patient histories'

 

Taking patient histories

Image icon of a person walking up the stairs representing 'Testing for changes in ability'

 

Testing for changes in ability

 

 

What is the YourMS questionnaire?

A questionnaire that encourages patients to reflect on their MS

  • A set of clinically relevant questions help patients to assess their MS symptoms over the previous 6 months
  • Patients complete the questionnaire in the comfort of their home
  • The user-friendly interface was developed with MS patients in mind, is easy to complete and uses patient-friendly language 

Image of a smartphone, computer monitor and a clipboard.

 

What are the benefits of using the YourMS questionnaire?

Each person’s MS is unique; therefore, YourMS questionnaire:

 

Image icon of a person with a lightning bolt next to it representing 'YourMS questionnaire enables patients with MS to come prepared for their consultations'

Enables patients with MS to come prepared for their consultations

 

Image icon of a dr and a patient with speech bubbles above representing 'YourMS questionnaire enables focussed conversations and increased patient engagement throughout the disease course'

Enables focussed conversations and increased patient engagement throughout the disease course

 

Image icon of a genome pedigree representing 'YourMS questionnaire encourages patients to reflect on their MS symptoms'

Encourages patients to reflect on their MS symptoms

 

Image icon of a calendar representing 'YourMS questionnaire helps patients take control of their MS'

Helps patients take control of their MS

 

 

What do other healthcare professionals (HCPs) think of YourMS?

Proportion of HCPs who ‘strongly agree’ or ‘agree’:

 

98.9% It was useful to my face-to-face or remote consultations with my patients to have the patient questionnaire completed

It was useful to my face-to-face or remote consultations with my patients to have the patient questionnaire completed4

 

 

100% The use of the questionnaire was helpful in making my patients more engaged in their MS

The use of the questionnaire was helpful in making my patients more engaged in their MS4

 

 

100% The use of the patient questionnaire positively influenced my clinical practice

The use of the patient questionnaire positively influenced my clinical practice4

 

 

HCP, healthcare professional; MS, multiple sclerosis; SPMS, secondary progressive multiple sclerosis.

References

  1. Inojosa H, et al. J Neurol. 2019;268:1210–1221.
  2. Davies F, et al. Int J MS Care. 2016;18:257–264.
  3. Gross HJ, Watson C. Neuropsychiatr Dis Treat. 2017;13:1349–1357.
  4. Ziemssen T, et al. Oral session: DXM01. Presentation at Consortium of Multiple Sclerosis Centers Annual Meeting, October 28 2021, Orlando, Florida.

 

Disclaimer

YourMS™ was developed and funded by Novartis Pharma AG. The Novartis Group of companies (in the UK, Novartis Pharmaceuticals UK Limited) does not collect any patient data from YourMS™; access to the information arising from this questionnaire is solely between the relevant HCP and the patient completing it. This website does not collect any personal data, however, please refer to the Privacy Policy below to learn how Novartis manages personal data collected via its websites. YourMS™ is a patient questionnaire for use by HCPs with their patients in clinical practice, aimed at facilitating and supporting HCP–patient interactions. It does not provide medical advice, diagnosis, prediction, prognosis or treatment advice. Any medical advice, diagnosis or treatment must be made in conjunction with all other available clinical information regarding the patient by an appropriate HCP. The use of YourMS™ is solely at the discretion of the relevant HCP(s) involved in the care and treatment of the patient, and the Novartis Group of companies hereby disclaims all warranties, whether express, implied or statutory, including but not limited to the implied warranties of merchantability and fitness for a particular purpose are hereby disclaimed and excluded to the fullest extent of the law. Terms of Use and Privacy Policy (https://www.novartis.co.uk/website-privacy-policy-0).

Rate this content: 
No votes yet
UK | June 2022 | 210620

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at www.novartis.com/report
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]